首页|探讨分子诊断技术对结核病ICD-10编码质量的影响

探讨分子诊断技术对结核病ICD-10编码质量的影响

扫码查看
分子诊断技术作为快速结核诊断技术,有助于结核病的早期诊断与治疗,降低结核病传播风险,但在ICD-10中呼吸系统结核类目分类轴心是实验室对结核杆菌检查的证实情况,该类目下只提及细菌学和组织学证实情况,导致由分子诊断技术确诊的结核病例容易出现错误编码.分子诊断技术既不是痰镜检,也不是痰培养或组织学技术,但是作为结核的确诊标准,在编码时应归类到"A15.3肺结核,经未特指的方法所证实".利福平耐药结核病作为二线抗结核药物治疗的疾病,按照目前我国通用的《疾病分类代码国家临床版2.0》进行分类,也需要进一步明确.编码员在面对新的诊疗技术带来的编码挑战时,应保持严谨的工作态度和持续学习的理念,通过多学科协作提高疾病编码准确性.
The Impact of Molecular Diagnostic Techniques on Tuberculosis Coding Using ICD-10
As a rapid tuberculosis diagnosis technology,molecular diagnostic technology helps in the early diagnosis and treatment of tuberculosis and reduces the risk of tuberculosis transmission.However,in ICD-10 coding,the classification axis of respiratory tuberculosis is the laboratory confirmation of tuberculosis bacilli.This category only mentions bacteriological and histological confirmation,which can easily lead to incorrect coding of tuberculosis cases confirmed by molecular diagnostic techniques.Molecular diagnostic techniques do not belong to sputum microscopy,nor sputum culture or histological techniques.However,as a diagnostic criterion for tuberculosis,it should be classified as"A15.3 Tuberculosis of lung,confirmed by unspecified means"when coding.Meanwhile,rifampicin-resistant tuberculosis,as a disease treated with second-line anti-tuberculosis drugs,needs to be further clarified according to the current"Disease Classification Code National Clinical Version"commonly used in China.When facing the coding challenges brought about by new diagnostic and treatment technologies,coders should maintain a rigorous work attitude and a concept of continuous learning and improve the accuracy of disease coding through multidisciplinary collaboration.

Molecular diagnostic techniquesPulmonary tuberculosisRifampicin-resistant tuberculosis

彭城、苏静、黄颖、纪德胜、莫彩凤、欧阳皓华、任妮丽

展开 >

武汉市肺科医院,湖北省,武汉市,430030

泰康同济(武汉)医院,湖北省,武汉市,430050

分子诊断技术 肺结核 利福平耐药结核

2024

中国病案
中国医院协会

中国病案

CSTPCD
影响因子:1.197
ISSN:1672-2566
年,卷(期):2024.25(11)